规模、所有制与中国医药制造业全要素生产率

Scale,Ownership and Total Factor Productivity of Pharmaceutical Manufacturing Industry in China

使用中国工业企业数据库的微观数据,将全要素生产率的平均增长率加入到生产函数中,对医药制造业全要素生产率的平均增长率进行了直接估计。通过将所有企业分为大型、中型、小型三大类,发现从总体上来看,规模越大的企业全要素生产率平均增长率越高。在控制住规模变量后,大型、中型国有医药制造业企业的全要素生产率平均增长率较高,而且高于外资企业。应鼓励大中型国有医药制造业企业继续做大做强,同时引导外资、私营企业良性发展,发挥多种所有制经济的优势,以此来促进我国医药制造业的健康发展。

Using the micro-level data of Chinese Industrial Enterprise Database, pharmaceutical manufacturing industry＇s average growth rate of total factor productivity is directly estimated by adding the average growth rate of total factor productivity to production function. If all the enterprises are divided into large scale, medium scale and small scale, the conclusion goes to that the larger the scale is, the higher the average growth rate of total factor productivity becomes in general. If the scale variable is controlled, the large, medium scale state-owned pharmaceutical manufacturing enterprises＇ average growth rate of total factor productivity is higher than that of foreign enterprises. In order to promote healthy development of China＇s pharmaceutical manufacturing, the state shall encourage the large, medium scale state-owned pharmaceutical manufacturing enterprises to become bigger and stronger. By the way, the state shall also guide foreign enterprises and private enterprises to develop soundly and exert the advantage of economy with different types of own- ership.